Live Breaking News & Updates on Reviva Pharmaceuticals Inc

Stay updated with breaking news from Reviva pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tourette Syndrome Market To Register Phenomenal Growth in the Period of 2026 – KSU


The 
Tourette Syndrome Market research report thoroughly explains each and every aspect related to the Global Tourette Syndrome Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
Tourette Syndrome Market Insight:
Global Tourette syndrome market is set to witness a substantial CAGR of 5% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to increasing demand for Tourette (too-RET) syndrome treatment.
This Free report sample includes: 
A brief introduction to the research report. ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , Asia Pacific , Eli Lilly , Sun Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries Ltd , Clinical Research Gmb , Emalex Biosciences Inc , Pfizer Inc , Reviva Pharmaceuticals Inc , Boehringer Ingelheim International Gmb , Johnson Services Inc , Bausch Health Companies Inc , Co Ltd , Otsuka Holdings Co , Neurocrine Biosciences Inc , Research Methodology , Market Research , Contents Of This Premium Research , Therapix Biosciences Ltd , Tourette Syndrome Market , Global Tourette Syndrome Market , Syndrome Market Insight ,

Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.


Share:
Combined Company to Trade on NASDAQ Post-closing under Tickers: RVPH and RVPHW
NEW YORK and CUPERTINO, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) Reviva Pharmaceuticals Holdings, Inc., a Delaware corporation (
Reviva Holdings ), as the successor to Tenzing Acquisition Corp., a special purpose acquisition company incorporated in the British Virgin Islands (
Tenzing ) (NASDAQ:TZAC), and Reviva Pharmaceuticals, Inc., a Delaware corporation (
Reviva ), a California-based clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced the completion of their previously announced business combination of the two companies (the ....

United States , State Of Delaware , British Virgin Islands , Parag Saxena , Bruce Mackle , Reviva Pharmaceuticals Holdings Inc , Neither Reviva Holdings , Ellenoff Grossman Schole , Board Of Directors Reviva Holdings , Reviva Holding , Maxim Group , Tenzing Acquisition Corp , Reviva Pharmaceuticals Inc , Lifesci Advisors , Drug Administration , Reviva Holdings , Exchange Commission , Company To , Lowenstein Sandler , Reviva Holdings Or , Combined Company , Pharmaceuticals Holdings , Reviva Pharmaceuticals , Merger Agreement , Business Combination , Laxminarayan Bhat ,